Efficacy of Gatifloxacin in Experimental Escherichia coli Meningitis

The effectiveness of gatifloxacin therapy (15 mg/kg every 5 h [q5h]) was compared with that of meropenem (75 mg/kg q5h) and cefotaxime (75 mg/kg q5h) therapy in experimental meningitis caused by a β-lactamase-producing strain of Escherichia coli. Gatifloxacin therapy was more rapidly bactericidal th...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Lutsar, Irja, Friedland, Ian R., Jafri, Hasan S., Wubbel, Loretta, Ng, Winston, Ghaffar, Faryal, McCracken, George H.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1999
Matèries:	Experimental Therapeutics
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89371/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10390250/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.7.1805
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!